CO6220833A2 - Inmuno reguladores preparaciones y composiciones que incluyen los inmuno-reguladores pruebas para evaluar la actividad de los inmuno-reguladores y preparaciones y composiciones que incluyen los mismos y metodos - Google Patents
Inmuno reguladores preparaciones y composiciones que incluyen los inmuno-reguladores pruebas para evaluar la actividad de los inmuno-reguladores y preparaciones y composiciones que incluyen los mismos y metodosInfo
- Publication number
- CO6220833A2 CO6220833A2 CO09043396A CO09043396A CO6220833A2 CO 6220833 A2 CO6220833 A2 CO 6220833A2 CO 09043396 A CO09043396 A CO 09043396A CO 09043396 A CO09043396 A CO 09043396A CO 6220833 A2 CO6220833 A2 CO 6220833A2
- Authority
- CO
- Colombia
- Prior art keywords
- immuno
- extract
- regulators
- preparations
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/70514—CD4
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Polymers & Plastics (AREA)
- Urology & Nephrology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
Abstract
1.- Una composición para mejorar la función inmune, que comprende: un componente de inmune-regulación, que incluye: una primera parte que incluye un primer extracto de una fuente de inmuno-reguladores que tienen un corte de peso molecular superior de aproximadamente 10,000 Da, el extracto de productos de alimentos que incluye el factor de transferencia y las moléculas de inmuno-regulación de nanofracción que tiene pesos moleculares de aproximadamente 3,000 Da o menores; y una parte secundaria que incluye un extracto extra de una fuente de inmuno-reguladores que tienen un corte de peso molecular superior de aproximadamente 3,000 Da, el extracto incluye más moléculas inmuno-reguladoras de nanofracción que tienen pesos moleculares de aproximadamente 3,000 Da o menores. 2.- La composición tal como se describe en la reivindicación 1, caracterizada porque el extracto comprende un extracto de calostro bovino. 3.- La composición tal como se describe en la reivindicación 1, caracterizada porque el extracto comprende además un extracto de huevo de gallina. 4.- La composición tal como se describe en la reivindicación 3, caracterizada porque el segundo extracto comprende otro extracto de calostro bovino. 5.- La composición tal como se describe en la reivindicación 4, caracterizada porque otro extracto de calostro bovino comprende por lo menos aproximadamente el dos por ciento del peso del componente inmuno-regulador. 6.- La composición tal como se describe en la reivindicación 5, caracterizada porque: el extracto de calostro bovino comprende aproximadamente 68% del peso de los componentes inmuno-reguladores; y el extracto de huevo de gallina que comprende aproximadamente el 30% del peso del componente de inmuno-regulador.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84834806P | 2006-09-29 | 2006-09-29 | |
| US11/855,944 US10471100B2 (en) | 2006-09-29 | 2007-09-14 | Nanofraction immune modulators, preparations and compositions including the same, and associated methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6220833A2 true CO6220833A2 (es) | 2010-11-19 |
Family
ID=39261440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO09043396A CO6220833A2 (es) | 2006-09-29 | 2009-04-29 | Inmuno reguladores preparaciones y composiciones que incluyen los inmuno-reguladores pruebas para evaluar la actividad de los inmuno-reguladores y preparaciones y composiciones que incluyen los mismos y metodos |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US10471100B2 (es) |
| EP (1) | EP2068913B1 (es) |
| JP (3) | JP5592651B2 (es) |
| CN (1) | CN101553247B (es) |
| AU (1) | AU2007305076B2 (es) |
| CO (1) | CO6220833A2 (es) |
| EC (1) | ECSP099296A (es) |
| ES (1) | ES2658107T3 (es) |
| HK (1) | HK1138181A1 (es) |
| MX (1) | MX2009003324A (es) |
| MY (2) | MY158857A (es) |
| RU (2) | RU2518341C2 (es) |
| SG (1) | SG160430A1 (es) |
| TW (1) | TWI449530B (es) |
| WO (1) | WO2008042604A2 (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6866868B1 (en) * | 2003-09-15 | 2005-03-15 | 4Life Research, Lc | Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions |
| US9028882B2 (en) | 2005-05-02 | 2015-05-12 | 4Life Patents, Llc | Nutraceutical gels |
| MY162337A (en) | 2005-05-02 | 2017-06-15 | 4Life Res Llc | Transfer factor preparations and associated methods |
| US10471100B2 (en) * | 2006-09-29 | 2019-11-12 | 4Life Patents, Llc | Nanofraction immune modulators, preparations and compositions including the same, and associated methods |
| TW201105966A (en) * | 2009-05-05 | 2011-02-16 | 4Life Patents Llc | Methods and systems for assaying, maintaining, and enhancing the activity of the immune system of a subject |
| AU2011332053B2 (en) | 2010-11-23 | 2016-06-02 | Pantheryx, Inc. | Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications |
| CN102172360B (zh) * | 2011-02-17 | 2013-04-24 | 南京大学 | 一种牛初乳提取物及其提取方法和应用 |
| WO2013039373A2 (es) * | 2011-09-13 | 2013-03-21 | Zepeda Lopez Hector Manuel | Extracto dializado de leucocitos de origen bazo de tiburón, para la obtención de factor de transferencia potencializado, y método de extracción, comprobación y conteo del mismo |
| WO2013039374A2 (es) * | 2011-09-15 | 2013-03-21 | Zepeda Lopez Hector Manuel | Método de extracción, comprobación y conteo de extracto dializado de leucocitos de origen bazo de tiburón, para la obtención de factor de transferencia potencializado, específicamente diseñado para su uso como tratamiento contra la enfermedad conocida como vitíligo |
| WO2013043032A2 (es) * | 2011-09-19 | 2013-03-28 | Zepeda Lopez Hector Manuel | Extracto dializado de leucocitos de origen bazo de tiburón para la obtención de factor de transferencia potencializado, específicamente diseñado para su uso como inmunomodulador y método de extracción, comprobación y conteo del mismo |
| WO2013043033A2 (es) * | 2011-09-19 | 2013-03-28 | Zepeda Lopez Hector Manuel | Método de extracción, comprobacíon de extracto dializado de leucocitos de origen bazo de tiburón, para la obtención de factor de transferecia potencializado, específicamente diseñado para su uso como adyuvante potencializador de vacunas virales |
| WO2013058640A2 (es) * | 2011-10-20 | 2013-04-25 | Zepeda Lopez Hector Manuel | Método de extracción, comprobación y conteo de extracto dializado de leucocitos de origen bazo de tiburón, para la obtención de factor de transferencia potencializado, específicamente diseñado para su uso como tratamiento contra la enfermedad conocida como asma |
| MX338863B (es) * | 2011-12-16 | 2016-05-01 | Inst Politecnico Nacional | Metodo de obtencion de extracto dializable de leucocitos. |
| US9566305B2 (en) | 2013-10-13 | 2017-02-14 | 4Life Patents, Llc | Therapeutic compositions and methods for addressing physiological stresses and aging |
| KR101597540B1 (ko) * | 2014-01-22 | 2016-02-29 | 건국대학교 산학협력단 | 난황 추출물을 유효성분으로 함유하는 면역증강용 조성물 |
| AU2018283314A1 (en) * | 2017-06-15 | 2020-01-16 | Miradx | Biomarkers for predicting tumor response to and toxicity of immunotherapy |
| US10933097B1 (en) | 2020-03-05 | 2021-03-02 | King Saud University | Method of treating a bacterial infection using colostrum |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4402938A (en) * | 1980-05-29 | 1983-09-06 | Impro Products, Inc. | Food and the method of extracting the same from colostrum and milk |
| JPS60208919A (ja) * | 1983-11-25 | 1985-10-21 | アムトロン・インコ−ポレイテツド | トランスフア−フアクタ−を初乳から得る方法、こうして得られたトランスフア−フアクタ−及びその使用 |
| US4816563A (en) * | 1983-11-25 | 1989-03-28 | Amtron, Inc. | Process for obtaining transfer factor from colostrum, transfer factor so obtained and use thereof |
| US5585098A (en) * | 1993-11-23 | 1996-12-17 | Ovimmune, Inc. | Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants |
| WO1997036008A1 (en) * | 1996-03-26 | 1997-10-02 | Biotechnology Transfer, Inc. | Methods for measurement of lymphocyte function |
| WO1997035595A1 (en) | 1996-03-26 | 1997-10-02 | Dcv Biologics L.P. | Egg anti-inflammatory composition, method of isolation and use |
| US7169571B2 (en) * | 1997-09-12 | 2007-01-30 | Cylex, Inc. | Methods for measurement of lymphocyte function |
| CZ287956B6 (cs) * | 1997-11-04 | 2001-03-14 | Medipharm Cz, S. R. O. | Perorální přípravek k prevenci a léčbě parvovirózy psů |
| US20020044942A1 (en) * | 2000-09-18 | 2002-04-18 | Chisolm Biological Laboratory, Llc | Transfer factor composition and process for producing same |
| US6468534B1 (en) | 2000-09-21 | 2002-10-22 | 4Life Research, Lc | Methods for obtaining transfer factor from avian sources, compositions including avian-generated transfer factor, and methods of use |
| WO2002038164A1 (en) | 2000-11-08 | 2002-05-16 | Lorus Therapeutics Inc. | Combination preparation of a biological response modifier and an anticancer agent and uses thereof |
| US20030003117A1 (en) * | 2001-06-18 | 2003-01-02 | Michael Marenick | Hydrolyzed whole egg products & related methods |
| KR20040105710A (ko) * | 2002-02-11 | 2004-12-16 | 아르키온 라이프 사이언씨즈 엘엘씨 | 정제된 사이토킨 억제인자 |
| US20040005327A1 (en) * | 2002-05-16 | 2004-01-08 | Subramanian Iyer | Immune T-cell stimulation |
| WO2004041071A2 (en) | 2002-11-04 | 2004-05-21 | 4Life Research, Lc | Compositions, systems, and methods for focusing a cell-mediated immune response |
| CN1460522A (zh) | 2003-06-16 | 2003-12-10 | 郭占军 | 预防和治疗疾病的蛋黄抗体组合物及其制备方法 |
| US6866868B1 (en) * | 2003-09-15 | 2005-03-15 | 4Life Research, Lc | Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions |
| US10471100B2 (en) | 2006-09-29 | 2019-11-12 | 4Life Patents, Llc | Nanofraction immune modulators, preparations and compositions including the same, and associated methods |
| CN100502674C (zh) | 2005-10-13 | 2009-06-24 | 复旦大学 | 一种牛初乳和香菇提取物组合物及其制备方法和用途 |
-
2007
- 2007-09-14 US US11/855,944 patent/US10471100B2/en active Active
- 2007-09-19 EP EP07814934.1A patent/EP2068913B1/en active Active
- 2007-09-19 AU AU2007305076A patent/AU2007305076B2/en active Active
- 2007-09-19 SG SG201001981-8A patent/SG160430A1/en unknown
- 2007-09-19 MX MX2009003324A patent/MX2009003324A/es active IP Right Grant
- 2007-09-19 WO PCT/US2007/078947 patent/WO2008042604A2/en active Application Filing
- 2007-09-19 CN CN200780039690.XA patent/CN101553247B/zh active Active
- 2007-09-19 MY MYPI20091276A patent/MY158857A/en unknown
- 2007-09-19 RU RU2009116274/15A patent/RU2518341C2/ru active
- 2007-09-19 ES ES07814934.1T patent/ES2658107T3/es active Active
- 2007-09-19 JP JP2009530527A patent/JP5592651B2/ja active Active
- 2007-09-27 TW TW096135902A patent/TWI449530B/zh active
-
2009
- 2009-03-27 MY MYPI2013003021A patent/MY188915A/en unknown
- 2009-04-29 CO CO09043396A patent/CO6220833A2/es active IP Right Grant
- 2009-04-29 EC EC2009009296A patent/ECSP099296A/es unknown
-
2010
- 2010-04-07 HK HK10103400.6A patent/HK1138181A1/zh unknown
-
2014
- 2014-01-27 RU RU2014102562A patent/RU2619555C2/ru active
- 2014-03-10 JP JP2014046094A patent/JP2014129413A/ja active Pending
-
2016
- 2016-06-22 JP JP2016123656A patent/JP6401744B2/ja active Active
-
2019
- 2019-11-11 US US16/679,908 patent/US11197894B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010504988A (ja) | 2010-02-18 |
| EP2068913B1 (en) | 2017-11-01 |
| ECSP099296A (es) | 2010-02-26 |
| RU2619555C2 (ru) | 2017-05-16 |
| MX2009003324A (es) | 2009-06-30 |
| CN101553247B (zh) | 2015-08-19 |
| EP2068913A2 (en) | 2009-06-17 |
| US20080081076A1 (en) | 2008-04-03 |
| AU2007305076B2 (en) | 2011-04-28 |
| JP2014129413A (ja) | 2014-07-10 |
| US10471100B2 (en) | 2019-11-12 |
| RU2518341C2 (ru) | 2014-06-10 |
| WO2008042604A3 (en) | 2008-11-06 |
| ES2658107T3 (es) | 2018-03-08 |
| CN101553247A (zh) | 2009-10-07 |
| US11197894B2 (en) | 2021-12-14 |
| AU2007305076A1 (en) | 2008-04-10 |
| WO2008042604A2 (en) | 2008-04-10 |
| JP5592651B2 (ja) | 2014-09-17 |
| US20200069737A1 (en) | 2020-03-05 |
| SG160430A1 (en) | 2010-04-29 |
| RU2009116274A (ru) | 2010-11-10 |
| HK1138181A1 (zh) | 2010-08-20 |
| JP6401744B2 (ja) | 2018-10-10 |
| JP2016196491A (ja) | 2016-11-24 |
| TW200831116A (en) | 2008-08-01 |
| TWI449530B (zh) | 2014-08-21 |
| MY158857A (en) | 2016-11-15 |
| MY188915A (en) | 2022-01-13 |
| EP2068913A4 (en) | 2009-12-02 |
| RU2014102562A (ru) | 2015-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6220833A2 (es) | Inmuno reguladores preparaciones y composiciones que incluyen los inmuno-reguladores pruebas para evaluar la actividad de los inmuno-reguladores y preparaciones y composiciones que incluyen los mismos y metodos | |
| BRPI0809663A8 (pt) | Composição de vírus vivo atenuado, usos da mesma, métodos de diminuição da inativação de vírus vivo atenuado, e kit para diminuir a inativação de uma composição de vírus vivo atenuado. | |
| BR112022003021A2 (pt) | Modificação de pacotes mensageiros de plantas com lipídeos carregados | |
| BRPI0612669B8 (pt) | composição imunogênica, vacina, composição, e composição liofilizada | |
| BRPI0508540A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BR112019024264A2 (pt) | Antimitoscinas: inibidores direcionados da biogênese mitoconcrial para erradicação de células-tronco de câncer | |
| BRPI0706125A2 (pt) | molho instantÂneo para uso alimentÍcio, processo para o preparo do referido molho, bem como embalagem parcial ou completamente transparente | |
| CY1115825T1 (el) | Φαρμακευτικες συνθεσεις που περιεχουν λεβετιρακεταμη και διαδικασια παρασκευης τους | |
| BR112012011294A2 (pt) | composição nutritiva para promover o equilíbrio de microbiotas do intestino e a saúde | |
| BRPI0518542A2 (pt) | regimes para viscossuplementaÇço intra-articular | |
| BRPI0507593A (pt) | composições contendo cis-isÈmeros de um composto carotenóide e processo | |
| BR122019027966B8 (pt) | conjugado monomérico de derivado de caliqueamicina/anti-corpo anti-cd22 e uso dos mesmos | |
| BR112015030428A2 (pt) | composição de fragrância | |
| BR112021019262A2 (pt) | Uso de ciclo-his-pro (chp) para prevenir, atenuar ou tratar fibrose | |
| BR112015000320A2 (pt) | composições farmacêuticas dissuasivas de abuso, de liberação prolongada | |
| BRPI0411361A (pt) | composições oftálmicas contendo uma combinação sinérgica de dois polìmeros | |
| BRPI0516082A (pt) | poligalactomananos catiÈnicos de alto ds para produtos de cuidado com a pele | |
| BR112018070060A2 (pt) | composições para tratamento bucal com uma exibição de sabor eficiente | |
| BR112014006459A2 (pt) | composições de interomone e seu uso para modificar o comportamento nas diferentes espécies de vertebrados | |
| BRPI0408827A (pt) | composições oftálmicas preservadas | |
| BRPI0309421A8 (pt) | Método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia | |
| BRPI0516542A (pt) | composição de vacina eficaz na prevenção ou melhora de infecção pelo vìrus da influenza aviária; método para prevenir ou melhorar a eclosão de infecção pelo vìrus da influenza aviária | |
| BRPI0511135A (pt) | formulação de aerossol para a inalação de beta-agonistas | |
| BRPI0516224A (pt) | produto alimentìcio contendo um ou vários microorganismos vivos e pelo menos um ingrediente alimentìcio bioativo de interesse, processo de preparação do mesmo, e, utilização de um produto alimentìcio | |
| TW200726460A (en) | Anti-fatigue composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused | ||
| FG | Application granted |